中国结合医学杂志（英文版）Chinese Journal of Integrative Medicine

Home

Chinese Version

Online office

Journal Online

Forthcoming Articles

Current Issue

Next Issue

Earlier Issues

Download

Editorial Board [2019/7/26]

Instructions for Authors [2015/1/26]

Instructions to Contributors [2013/3/25]

Top

Top Downloaded
Top Cited

Links

alljournals

扫描微信二维码，获取更多信息

Ef?cacy of Gastrosis No.1 Compound on Functional Dyspepsia of Spleen and Stomach De?ciency-Cold Syndrome: A Multi-Center, Double-Blind, Placebo-Controlled Clinical Trial

View Full Text View/Add Comment Download reader

KeyWord:functional dyspepsia, Spleen and Stomach de?ciency-cold syndrome, randomized controlled trial

Author Name	Affiliation	E-mail
ZHANG Sheng-sheng	Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University, Beijing (100010), China	zhss2000@163.com
ZHAO Lu-qing, WANG Hong-bing, WU Bing

Hits: 1352

Download times: 1053

Abstract:

Objective: To assess the efficacy and safety of Gastrosis No.1 compound in the treatment of functional dyspepsia with Spleen (Pi) and Stomach (Wei) deficiency-cold syndrome. Methods: A randomized, double-blind, placebo-controlled trial was performed in 5 centers. Patients with functional dyspepsia (FD) of Spleen-deficiency and qi-stagnation syndrome (162 cases) were randomly assigned to groups given Chinese herbal medicine (CHM) Gastrosis No.1 compound or placebo in a 2:1 ratio. This trial included a 4-week treatment period and a 4-week follow-up period. The outcomes were the dyspepsia symptom scores (measured by total dyspepsia symptom scale and single dyspepsia symptom scale) and syndromes of traditional Chinese medicine score (measured by traditional Chinese medicine syndrome scale). The outcomes were noted at weeks 0, 4 and 8. Results: Compared with patients in the placebo group, patients in the CHM group showed significant improvement in the dyspepsia symptom scores as rated by patients and investigators (P<0.01), and also showed improvement in syndromes of traditional Chinese medicine score (P<0.01). No serious adverse event was reported. Safety tests obtained after 4 weeks of treatment showed no abnormal values. Conclusion: CHM Gastrosis No.1 compound was effective and safe in the treatment of functional dyspepsia with Spleen and Stomach deficiency-cold syndrome.